Patent Assignment
Reel/Frame 014532/0840
Security Agreement
Recorded: 2003-09-29
Received: 2003-10-02
Pages: 12
Assignor
HIPPOCAMPE S.A.
Executed: 2001-03-28
Assignee
MFC MERCHANT BANK S.A.
KASERNENSTRASSE 1, HERISAU, AR 9100, CHX, SWITZERLAND
Covered Properties
(8)
Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells
Application:
10/457,780 →
Highly-conserved HIV-GP41 peptides based on molecular mimicry are potent inhibitors of HIV-1 replication
Application:
60/446,268 →
Peptides and use thereof in therapeutic agents against HIV infection
Application:
10/305,133 →
Peptide as inhibitors of HIV infection
Application:
60/413,919 →
A Polynucleotide Encoding a Mutated Hiv GP41 Polypeptide
Application:
10/198,938 →
Potent inhibition of HIV-1 infectivity in vitro of a gp41-derived synthetic peptide
Application:
60/386,754 →
Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections
Application:
09/979,271 →
Polypeptide inhibiter of HIV infectivity
Application:
60/340,492 →